JP2022534680A5 - - Google Patents
Info
- Publication number
- JP2022534680A5 JP2022534680A5 JP2021568274A JP2021568274A JP2022534680A5 JP 2022534680 A5 JP2022534680 A5 JP 2022534680A5 JP 2021568274 A JP2021568274 A JP 2021568274A JP 2021568274 A JP2021568274 A JP 2021568274A JP 2022534680 A5 JP2022534680 A5 JP 2022534680A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- domain
- immune cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019087260 | 2019-05-16 | ||
| CNPCT/CN2019/087260 | 2019-05-16 | ||
| PCT/CN2020/090600 WO2020228824A1 (en) | 2019-05-16 | 2020-05-15 | Immune cell receptors comprsing cd4 binding moieties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022534680A JP2022534680A (ja) | 2022-08-03 |
| JP2022534680A5 true JP2022534680A5 (enExample) | 2023-05-22 |
Family
ID=73289800
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568290A Withdrawn JP2022533621A (ja) | 2019-05-16 | 2020-05-15 | 認識分子を含む操作された免疫細胞 |
| JP2021568274A Ceased JP2022534680A (ja) | 2019-05-16 | 2020-05-15 | Ｃｄ４結合部分を含む免疫細胞受容体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568290A Withdrawn JP2022533621A (ja) | 2019-05-16 | 2020-05-15 | 認識分子を含む操作された免疫細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20220241330A1 (enExample) |
| EP (2) | EP3969572A4 (enExample) |
| JP (2) | JP2022533621A (enExample) |
| KR (2) | KR20220009966A (enExample) |
| CN (3) | CN113840912A (enExample) |
| AU (2) | AU2020275049A1 (enExample) |
| SG (2) | SG11202112536UA (enExample) |
| WO (2) | WO2020228825A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7711945B2 (ja) | 2019-04-30 | 2025-07-23 | センティ バイオサイエンシズ インコーポレイテッド | キメラ受容体及びその使用方法 |
| US20240050474A1 (en) * | 2021-02-09 | 2024-02-15 | Nanjing Legend Biotech Co., Ltd. | Engineered cells and uses thereof |
| GB202105682D0 (en) * | 2021-04-21 | 2021-06-02 | Imp College Innovations Ltd | Chimeric antigen receptor (CAR)-T cells |
| GB202105684D0 (en) * | 2021-04-21 | 2021-06-02 | Imperial College Innovations Ltd | Chimeric antigen receptor (CAR)-T cells |
| EP4381081A1 (en) | 2021-08-04 | 2024-06-12 | Sana Biotechnology, Inc. | Use of cd4-targeted viral vectors |
| WO2023114949A1 (en) | 2021-12-16 | 2023-06-22 | Sana Biotechnology, Inc. | Methods and systems of particle production |
| US20250082777A1 (en) | 2022-01-10 | 2025-03-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023150647A1 (en) | 2022-02-02 | 2023-08-10 | Sana Biotechnology, Inc. | Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| US20260027145A1 (en) | 2022-07-27 | 2026-01-29 | Sana Biotechnology, Inc. | Methods of transduction using a viral vector and inhibitors of antiviral restriction factors |
| WO2024044655A1 (en) | 2022-08-24 | 2024-02-29 | Sana Biotechnology, Inc. | Delivery of heterologous proteins |
| EP4590688A1 (en) | 2022-09-21 | 2025-07-30 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| CN115819622A (zh) * | 2022-09-26 | 2023-03-21 | 湖南省人民医院(湖南师范大学附属第一医院) | 针对b系白血病或淋巴瘤的双靶点car结构及药物组合物 |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| WO2024220597A2 (en) | 2023-04-18 | 2024-10-24 | Sana Biotechnology, Inc. | Digital droplet based assay for detecting replication competent lentiviral vector |
| CN116836284A (zh) * | 2023-04-21 | 2023-10-03 | 浙江正熙生物技术有限公司 | 一种抗人cd4抗体及其制备方法和应用 |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| WO2025068899A1 (en) * | 2023-09-25 | 2025-04-03 | Janssen Biotech, Inc. | Compositions and methods for the generation of engineered, and or engineerable, cells |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| WO2026032970A1 (en) | 2024-08-07 | 2026-02-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Cd4-specific chimeric antigen receptor and methods and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ594784A (en) * | 2005-08-18 | 2013-06-28 | Genmab As | Therapy with CD4 binding peptides and radiation |
| EP2814846B1 (en) * | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| CN104822705B (zh) * | 2012-10-24 | 2019-07-12 | 美国卫生和人力服务部 | M971嵌合抗原受体 |
| US10577417B2 (en) * | 2014-09-17 | 2020-03-03 | Novartis Ag | Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy |
| HRP20240357T1 (hr) * | 2014-12-24 | 2024-06-07 | Autolus Limited | Stanica |
| CA2977106A1 (en) * | 2015-02-27 | 2016-09-01 | Icell Gene Therapeutics Llc | Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof |
| PL3280729T3 (pl) * | 2015-04-08 | 2022-08-22 | Novartis Ag | Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19 |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| GB201601077D0 (en) * | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibody molecule |
| WO2017177175A1 (en) * | 2016-04-07 | 2017-10-12 | The George Washington University | Methods and compositions targeting retroviral latency |
| AU2017312887A1 (en) * | 2016-08-13 | 2019-03-07 | United BioPharma, Inc. | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients |
| CN117298260A (zh) * | 2016-09-02 | 2023-12-29 | 莱蒂恩技术公司 | 用DuoCAR治疗癌症的组合物和方法 |
| CN107964549B (zh) * | 2016-10-20 | 2020-12-08 | 上海恒润达生生物科技有限公司 | 靶向cd22的嵌合抗原受体及其用途 |
| WO2019020733A1 (en) * | 2017-07-26 | 2019-01-31 | Cellectis | METHODS OF IMMUNE CELL SELECTION OF THE ANTIGEN-DEPENDENT CHIMERIC ANTIGENIC RECEPTOR (CAR) |
| KR20210031898A (ko) * | 2018-07-13 | 2021-03-23 | 난징 레전드 바이오테크 씨오., 엘티디. | 전염병을 치료하기 위한 공동수용체 시스템 |
-
2020
- 2020-05-15 CN CN202080036374.2A patent/CN113840912A/zh active Pending
- 2020-05-15 KR KR1020217038368A patent/KR20220009966A/ko not_active Withdrawn
- 2020-05-15 SG SG11202112536UA patent/SG11202112536UA/en unknown
- 2020-05-15 CN CN202410461081.9A patent/CN118420762A/zh not_active Withdrawn
- 2020-05-15 CN CN202080036396.9A patent/CN113825766A/zh active Pending
- 2020-05-15 WO PCT/CN2020/090601 patent/WO2020228825A1/en not_active Ceased
- 2020-05-15 KR KR1020217038372A patent/KR20220010722A/ko not_active Withdrawn
- 2020-05-15 AU AU2020275049A patent/AU2020275049A1/en not_active Abandoned
- 2020-05-15 EP EP20806230.7A patent/EP3969572A4/en not_active Withdrawn
- 2020-05-15 EP EP20806600.1A patent/EP3969471A4/en active Pending
- 2020-05-15 WO PCT/CN2020/090600 patent/WO2020228824A1/en not_active Ceased
- 2020-05-15 AU AU2020274569A patent/AU2020274569A1/en not_active Abandoned
- 2020-05-15 JP JP2021568290A patent/JP2022533621A/ja not_active Withdrawn
- 2020-05-15 US US17/611,543 patent/US20220241330A1/en not_active Abandoned
- 2020-05-15 US US17/611,542 patent/US20220265711A1/en not_active Abandoned
- 2020-05-15 JP JP2021568274A patent/JP2022534680A/ja not_active Ceased
- 2020-05-15 SG SG11202112554UA patent/SG11202112554UA/en unknown